T cell-redirecting antibody for treatment of solid tumors via targeting mesothelin.
Liu JJ, Pan ZD, Yue YL, Wang SS, Chen J, Jiang H, Zhang BH, Wu MY, Yuan YS, Bian YL, Yin HY, Wang L, Li JY, Gilly J, Xie YQ, Zhu JW.
Liu JJ, et al. Among authors: xie yq.
Acta Pharmacol Sin. 2024 Oct;45(10):2186-2198. doi: 10.1038/s41401-024-01316-6. Epub 2024 Jun 10.
Acta Pharmacol Sin. 2024.
PMID: 38858494